Predictors of vascular disease in myelodysplastic syndromes
Mark G. Faber David R. Lloyd Abhay Singh Jeffrey Baron Amanda Przespolewski Elizabeth A. Griffiths Eunice S. Wang Swapna Thota, eJHaem, 9/28/2020Current State of Myelodysplastic Syndromes: Standard Treatment Practices and Therapeutic Advances
Mark G Faber, DO; Elizabeth A Griffiths, MD; Swapna Thota, MD, Journal of Clinical Pathways, 7/2019